CTOs on the Move

Prematics

www.prematics.com

 
Prematics, Inc is a Mclean, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.prematics.com
  • 8484 Westpark Dr Ste 150
    Mclean, VA USA 22102
  • Phone: 703.956.5500

Executives

Name Title Contact Details

Similar Companies

The Villas Luxury Senior Living NJ

The Villas is a luxury senior living community in New Jersey that offers upscale assisted living and personalized care. They provide a resort-like experience with luxury apartments and a wide range of amenities.

Ulrich Medical Concepts

Ulrich Medical Concepts is a Paducah, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Velcera

Velcera is a Yardley, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Patient Advocate Foundation Inc

Patient Advocate Foundation Inc is a Hampton, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kymera Therapeutics

Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.